Company / Net Income
Mereo BioPharma Group plc Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$41.9M
FY2025
5-year range
-$43.3M / -$29.5M
FY2023-FY2025
Trend
+3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$29M to -$42M over the past 2 years.
Based on SEC 10-K filings.
-$42M in FY2025.
Declined from -$29M to -$42M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 3.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$41.9M | +3.2% |
| FY2024 | -$43.3M | -46.8% |
| FY2023 | -$29.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 27, 2026